Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling

Most pancreatic neuroendocrine tumors (PNETs) are indolent, while pancreatic ductal adenocarcinomas (PDACs) are particularly aggressive. To elucidate the basis for this difference and to establish the biomarkers, by using the deep sequencing, we analyzed somatic variants across coding regions of 409...

Descripción completa

Detalles Bibliográficos
Autores principales: Starzyńska, Teresa, Karczmarski, Jakub, Paziewska, Agnieszka, Kulecka, Maria, Kuśnierz, Katarzyna, Żeber-Lubecka, Natalia, Ambrożkiewicz, Filip, Mikula, Michał, Kos-Kudła, Beata, Ostrowski, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352720/
https://www.ncbi.nlm.nih.gov/pubmed/32586046
http://dx.doi.org/10.3390/ijms21124470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352720/
https://www.ncbi.nlm.nih.gov/pubmed/32586046
http://dx.doi.org/10.3390/ijms21124470

Ejemplares similares